TP53 and colonic neoplasm: The in vitro results showed that in colon cancer cell lines, mutated TP53 is inhibited by exogenous miR-125b causing inhibition of colony formation ability, invasion, and metastasis, while wild-type TP53 is not affected, concomitant with minimal phenotypical differences.